Sectors

Merck & Co and UnitedHealth Group are set to exit the urologic cancer diagnostics technology provider in an acquisition by Veracyte.

The Cambrian Biopharma-backed cancer treatment developer floated above its range in an offering on the Nasdaq Global Market.

Intact Ventures led an $11.5m round for the business insurance software provider that was also backed by Lackawanna Insurance Group.

The share trading platform operator reportedly secured a combination of equity and debt funding to face obligations arising from the recent stock market frenzy.

Saudi Aramco Energy Ventures returned to contribute to a round that will support development of a pilot version of NexWafe's solar wafer production technology.

Young Sohn is retiring while Luc Julia is leaving as Sean Kae and David Lee step up and into Samsung Catalyst and Samsung Next respectively.

Gene-sequencing technology developer Vision Medicals has completed a $30.9m round led by Tencent that took its total funding to approximately $74m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The Tencent and Baidu-backed livestreaming app saw its shares almost triple on the first day of trading and is now valued at about $160bn.

The corporate-backed genetic testing service is joining forces with an NYSE-listed special purpose acquisition company sponsored by Virgin Group.

The Alphabet-backed immunotherapy developer secured nearly $588m in what was reputedly the largest ever flotation for a preclinical life sciences company.